19c96fd517d854497e8-630f 20211225035555514 beie:beie director@blueeyesintelligence.org WEB-FORM International Journal of Recent Technology and Engineering (IJRTE) IJRTE 22773878 10.35940/ijrte.2277-3878 https://www.ijrte.org/ 01 30 2022 10 5 10.35940/ijrte.10.5 https://www.ijrte.org/download/volume-10-issue-5/ 4th Year BA. LLB Candidate, O.P. Jindal Global University, Jindal Global Law School, Sonipat, India. Ahan Gadkari Sofia Dash 1st Year BA. LLB Candidate, O.P. Jindal Global University, Jindal Global Law School, Sonipat, India. The availability of vaccinations against COVID-19 provides hope for containing the epidemic, which has already claimed over 2.84 million lives. However, inoculating millions of individuals worldwide would need large vaccine manufacturing followed by fair distribution. A barrier to vaccine development and dissemination is the developers' intellectual property rights. India and South Africa have jointly sought to the World Trade Organization that certain TRIPS rules of COVID-19 vaccines, medicines, and treatments be waived. This piece argues for such a waiver, highlighting the unique circumstances that exist. It believes that TRIPS's flexibilities are inadequate to cope with the present epidemic, particularly for nations without pharmaceutical manufacturing competence. 01 30 2022 61 65 CC BY-NC-ND 4.0 10.35940/BEIESP.CrossMarkPolicy www.ijrte.org true 10.35940/ijrte.E6675.0110522 https://www.ijrte.org/portfolio-item/e66750110522/